Claims for Patent: 5,595,873

Summary for Patent: 5,595,873

Title:	T. thermophila group I introns that cleave amide bonds
Abstract:	The present invention relates to nucleic acid enzymes or enzymatic RNA molecules that are capable of cleaving a variety of bonds, including phosphodiester bonds and amide bonds, in a variety of substrates. Thus, the disclosed enzymatic RNA molecules are capable of functioning as nucleases and/or peptidases. The present invention also relates to compositions containing the disclosed enzymatic RNA molecule and to methods of making, selecting, and using such enzymes and compositions.
Inventor(s):	Joyce; Gerald F. (Encinitas, CA)
Assignee:	The Scripps Research Institute (La Jolla, CA)
Application Number:	08/270,180
Patent Claims:	1. An enzymatic RNA molecule comprising a ribonucleotide polymer having a nucleotide sequence from the group I intron of T. thermophila, wherein said polymer catalyzes the hydrolysis of amide bonds in a substrate, and wherein said substrate comprises an oligonucleotide containing an amide, bond. 2. The enzymatic RNA molecule of claim 1, wherein said polymer has a catalytic activity for hydrolyzing said substrate to produce an amino cleavage product and a ribozyme amidase intermediate. 3. The enzymatic RNA molecule of claim 2, wherein: a. said ribonucleotide polymer has a 5' terminal nucleotide with a ribose sugar having a nucleophilic 2' hydroxyl; and b. said ribozyme amidase intermediate includes an ester linkage between said nucleophilic 2' hydroxyl and a carboxy group of said substrate. 4. The enzymatic RNA molecule of claim 3, wherein said 5' terminal nucleotide includes a guanine base. 5. The enzymatic RNA molecule of claim 3, wherein said substrate includes a peptide having two or more amino acid residues including a carboxy terminal amino acid residue bearing the carboxy group of said substrate, said carboxy terminal amino acid residue being covalently linked by the ester linkage to the 2' hydroxyl of said ribonucleotide polymer. 6. The enzymatic RNA molecule of claim 2, wherein said ribonucleotide polymer has an effective binding affinity for said substrate and lacks an effective binding affinity for said amino cleavage product. 7. The enzymatic RNA molecule of claim 1, further comprising a cofactor bound to said ribonucleotide polymer, said cofactor including a guanine nucleotide having a ribose sugar with a nucleophilic 2' hydroxyl capable of forming an acid labile ester intermediate with the carboxy cleavage product. 8. The enzymatic RNA molecule of claim 1, wherein said nucleotide sequence comprises SEQ ID NO 1 and further includes one or more of the following mutations: 9. A ribozyme amidase intermediate comprising: a. a ribonucleotide polymer having a nucleotide sequence from the group I intron of T. thermophila and further including a 5' terminal nucleotide with a ribose sugar having a 2' hydroxyl; and b. a substrate molecule comprising an oligonucleotide containing an amide bond and having one or more amino acid residues including a carboxy terminal amino acid residue, said carboxy terminal amino acid residue being covalently linked by an ester bond to the 2' hydroxyl of said ribonucleotide polymer. 10. The ribozyme amidase intermediate of claim 9, wherein said ribonucleotide polymer comprises SEQ ID NO 1 and further includes one or more of the following mutations: 11. A ribozyme amidase intermediate comprising: a. a ribonucleotide polymer having a nucleotide sequence from the group I intron of T. thermophila; b. a cofactor including a guanine nucleotide having a ribose sugar with a 2' hydroxyl; and c. a substrate molecule comprising an oligonucleotide containing an amide bond and having one or more amino acid residues including a carboxy terminal amino acid residue, said carboxyl terminal amino acid residue being covalently linked by an ester bond to the 2' hydroxyl of said guanine nucleotide. 12. The ribozyme amidase intermediate of claim 11, wherein said ribonucleotide polymer comprises SEQ ID NO 1 and further includes one or more of the following mutations: 13. A method for catalytically hydrolyzing a substrate comprising an oligonucleotide containing an amide bond, the method comprising the following step A: contacting said substrate with a ribozyme comprising a ribonucleotide polymer having a nucleotide sequence from the group I intron of T. thermophila and having a catalytic activity for hydrolyzing said substrate and producing an amino cleavage product and a ribozyme amidase intermediate, said ribozyme amidase intermediate including a carboxyl of said substrate bonded by an ester bond to a 2'0 hydroxyl of a ribose sugar on a 5' terminal nucleotide of the ribonucleotide polymer. 14. A method for catalytically hydrolyzing a substrate as described in claim 13, the method further comprising step B as follows, to be performed after said Step A: hydrolyzing the ester bond of said ribozyme amidase intermediate to produce a carboxy cleavage product. 15. A method of cleaving an amide bond, comprising: a. admixing an enzymatic RNA molecule according to claim 1 with a substrate comprising an oligonucleotide containing an amide bond, to form a reaction admixture; and b. maintaining said admixture under predetermined reaction conditions to allow said enzymatic RNA molecule to cleave said amide bond. 16. The method of claim 15, wherein said enzymatic RNA molecule is able to cleave an amide bond at a preselected site. 17. The method of claim 15, further comprising the steps of: a. separating said products from said enzymatic RNA molecule; and b. adding additional substrate to said enzymatic RNA molecule to form a new reaction admixture. 18. A method of selecting an enzymatic RNA molecule that cleaves amide bonds, comprising the following consecutive steps: a. admixing amide bond-containing oligonucleotide substrate molecules with a population of T. thermophila group I introns (ribozymes) to form an admixture; b. maintaining said admixture for a sufficient period of time and under predetermined reaction conditions to allow said ribozymes and said substrate to interact and form ribozyme-product complexes; c. isolating any ribozyme-product complexes that form; d. allowing said ribozyme-product complex to dissociate into separate ribozyme and product; and e. separating said ribozymes from said product. 19. The method of claim 18, wherein said substrate is tagged with an immobilizing agent. 20. A method of engineering enzymatic RNA molecules that cleave amide bonds, comprising the following steps: a. introducing genetic variation into a population of T. thermophila group I introns (ribozymes) to produce a variant population; b. selecting individuals from said variant population that meet predetermined selection criteria; c. separating said selected individuals from the remainder of said variant population; and d. amplifying said selected individuals.

Details for Patent 5,595,873

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2014-05-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2014-05-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2014-05-13